title: Influence of Atorvastatin on Plasma Atherogenic Biomarkers
abstract: Patients (n = 40) with hypercholesterolaemia (29 females), mean age 63 years, without previous lipid lowering treatment, were treated with atorvastatin 40 mg/day for 3 months. Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), LDL-C subfractions (large LDL-C and small dense LDL-C particles), apolipoprotein A1 (apo A1), apolipoprotein B (apo B), apo B/apo A1 ratio, atherogenic index of plasma (AIP), haematological
journal: InTech eBooks